FASS SIMCHA 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Oct 5, 2004
Insider Transaction Report
Form 4
FASS SIMCHA
Director
Transactions
- Award
Options to purchase Common Stock, $.01 par value per share
2004-09-30$2.30/sh+4,347$9,998→ 1,314,447 totalExercise: $2.30From: 2005-09-30Exp: 2014-09-30→ Common Stock, $.01 par value per share (4,347 underlying)
Footnotes (1)
- [F1]These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $3,750.00, until he is no longer an Outside Director. On September 30, 2004, the fair market value of the Common Stock, based on the closing price, was $2.30. Dr. Fass became a non-employee director on 7/12/2004 and therefore he only was granted 4,347 shares for the quarter. These options will become fully vested and immediately exercisable on 9/30/2005.